Cryoport Balance Sheet Health
Financial Health criteria checks 5/6
Cryoport has a total shareholder equity of $418.6M and total debt of $199.3M, which brings its debt-to-equity ratio to 47.6%. Its total assets and total liabilities are $701.8M and $283.2M respectively.
Key information
47.6%
Debt to equity ratio
US$199.29m
Debt
| Interest coverage ratio | n/a |
| Cash | US$272.67m |
| Equity | US$418.57m |
| Total liabilities | US$283.19m |
| Total assets | US$701.77m |
Recent financial health updates
Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Nov 06
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Jul 22Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Recent updates
Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)
Dec 03Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Nov 06The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More
Aug 09Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Jul 22Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch
Jun 25Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Cryoport: An Industry Leader Basking In Industry Tailwinds
Apr 15Cryoport: Risky Investment With Upside Potential
Apr 01Cryoport: More Growth Going Into New Year 2022
Dec 29Financial Position Analysis
Short Term Liabilities: CYRX's short term assets ($350.3M) exceed its short term liabilities ($61.4M).
Long Term Liabilities: CYRX's short term assets ($350.3M) exceed its long term liabilities ($221.8M).
Debt to Equity History and Analysis
Debt Level: CYRX has more cash than its total debt.
Reducing Debt: CYRX's debt to equity ratio has increased from 13.4% to 47.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYRX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: CYRX has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 30.6% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 17:49 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cryoport, Inc. is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ashok Kumar | Aegis Capital Corporation |
| Yuan Zhi | B. Riley Securities, Inc. |
| Andrew D'Silva | B. Riley Securities, Inc. |